Surajeet Das Gupta &Amp; Sohini Das

Stories by Surajeet Das Gupta &Amp; Sohini Das

Rare-earth squeeze puts electric two-wheeler firms, suppliers at odds

Rare-earth squeeze puts electric two-wheeler firms, suppliers at odds

Rediff.com   24 Sep 2025

Electric two-wheeler (e2W) companies are upset with some of their suppliers of heavy rare-earth magnet-powered electric motors, who have objected to their proposal - under consideration by the government - that would allow e2W original equipment manufacturers (OEMs) an exemption from localisation norms on electric motors, thereby enabling them to continue receiving the 5,000-per-vehicle subsidy.V

When Romance Meets The Rulebook: How Cos Deal With Workplace Relationships

When Romance Meets The Rulebook: How Cos Deal With Workplace Relationships

Rediff.com   24 Sep 2025

Romance may be personal, but when it enters the workplace, particularly in reporting hierarchies, it becomes a matter of governance.

Luxury Cars, Bikes Rev Up For Festival Season

Luxury Cars, Bikes Rev Up For Festival Season

Rediff.com   23 Sep 2025

Luxury carmakers are shifting into high gear with a mix of product launches, personalised experiences and lifestyle-led engagement.

India tightens grip on global smartphone market by value

India tightens grip on global smartphone market by value

Rediff.com   19 Sep 2025

India is slowly expanding its share as the third-largest market for smartphones globally in terms of value, even as countries like China, at the top, and the UK, at fifth, have seen declines, according to global data from Counterpoint Research.

'Lenovo to Double 'Make in India' Devices in 2 Years'

'Lenovo to Double 'Make in India' Devices in 2 Years'

Rediff.com   13 Sep 2025

'We are increasing our footprint, but other markets also compete - like Indonesia or Vietnam.'

Patients to benefit from GST cut, but pharma firms may face margin pressure

Patients to benefit from GST cut, but pharma firms may face margin pressure

Rediff.com   12 Sep 2025

The rationalisation of goods and services tax (GST), announced on Wednesday, directly lowers the cost of everyday medical consumables, and also high-end therapies in oncology and rare diseases, helping reduce out-of-pocket patient expenditure and better adherence to medication.

Helped by GST move, PV sales growth may rebound to 7% by FY27: Maruti

Helped by GST move, PV sales growth may rebound to 7% by FY27: Maruti

Rediff.com   12 Sep 2025

The country's largest carmaker Maruti Suzuki India expects auto sales to bounce back to the glory days of 7 per cent growth by FY 27, helped by the proposed GST rate cut which is expected to bring down car prices by 3.5 to 8.5 per cent.

Rare Earth Magnet Crunch Persists For Automakers

Rare Earth Magnet Crunch Persists For Automakers

Rediff.com   11 Sep 2025

'Despite assurance from China, none of the companies have received supplies from Chinese sellers.'

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com   10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

Alto, Wagon R Prices May Drop By 40,000 To 67,000

Alto, Wagon R Prices May Drop By 40,000 To 67,000

Rediff.com   5 Sep 2025

'GST reduction will help larger and high-end cars too.'

Apple Boosts Output For iPhone 17 Launch

Apple Boosts Output For iPhone 17 Launch

Rediff.com   4 Sep 2025

India has become Apple's main export hub to the US, which consumes over $40 billion worth of iPhones annually.

100 New Fab Plants, India Aims Higher

100 New Fab Plants, India Aims Higher

Rediff.com   1 Sep 2025

'The world now realises that semiconductors are not just important for national security, but also for economic prosperity.'

55 Million E-Challans Issued Till June, But...

55 Million E-Challans Issued Till June, But...

Rediff.com   1 Sep 2025

Challans worth Rs 10,298 crore were issued, but collections have been a weak 20 per cent.

Classify Strategic Data As 'National Asset'

Classify Strategic Data As 'National Asset'

Rediff.com   29 Aug 2025

...on par with oil, power, and defence, and to restrict its storage under foreign control.

What July's Hiring Trends Reveal

What July's Hiring Trends Reveal

Rediff.com   21 Aug 2025

Fresher hiring grew by 8 per cent driven by non-IT services oil and gas, real estate, and education sectors.

Running for top spot, Asics eyes Nike and Adidas turf in India

Running for top spot, Asics eyes Nike and Adidas turf in India

Rediff.com   14 Aug 2025

It has charted an ambitious target. Japanese premium sports goods giant Asics - which sells 75 per cent of its shoes in the country at over ~12,000 a pair - wants to be the No. 1 running shoe player in the $90-a-pair organised market in India, currently dominated by Nike, Adidas and Puma. To do so, it is making an aggressive push into Tier-II and Tier-III cities, where customers are ready to lap them up - as well as setting up company-owned stores in four to five locations across key metros.

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

Rediff.com   12 Aug 2025

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.

Trump's Tariff Give Electronics A Breather

Trump's Tariff Give Electronics A Breather

Rediff.com   31 Jul 2025

But the respite may not last long.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com   31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

P&G's New Boss Is Big Into Bollywood Movies

P&G's New Boss Is Big Into Bollywood Movies

Rediff.com   30 Jul 2025

Shailesh Jejurikar has 'always made an effort to stay close to his roots.'